Clinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation

被引:5
|
作者
Ning, Hui [1 ,2 ]
Liu, Ming [1 ]
Wang, Lina [3 ]
Yang, Yang [1 ]
Song, Nan [1 ]
Xu, Xiaoxiong [1 ]
Ju, Jin [4 ]
Jiang, Gening [1 ]
机构
[1] Tongji Univ, Dept Thorac Surg, Shanghai Pulm Hosp, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
[2] Tianjin Haihe Hosp, Dept Thorac Surg, Tianjin 300350, Peoples R China
[3] Dalian Med Univ, Dept Endodont & Periodont, Coll Stomatol, Dalian 116044, Peoples R China
[4] Weihai Municipal Hosp, Dept Thorac Surg, 70 Heping Rd, Weihai 264200, Peoples R China
基金
中国博士后科学基金;
关键词
Lung cancer; epidermal growth factor receptor ( EGFR) gene; mutation; phenotype; genotype; EGFR MUTATIONS; TYROSINE KINASE; KRAS MUTATIONS; GEFITINIB; ADENOCARCINOMA; CHEMOTHERAPY; SENSITIVITY; INHIBITION; RESISTANCE; PATHWAYS;
D O I
10.21037/jtd.2017.03.13
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Epidermal growth factor receptor (EGFR) gene was the major causative gene of lung cancer and also the specific treatment target. It is necessary to analyze the genotype and phenotype characters of patients. Methods: We investigated 1,034 lung cancer patients in this study. The collected clinicopathological parameters included gender, age at diagnosis, smoking status, pathological TNM stage, tumor morphology and location, visceral pleural invasion as well as histological type. Results: Almost 50% participants had EGFR mutations. L858R in exon 21 was the most common type. Concomitant mutation, 19 del and L858R, were detected in 20 patients. Compared to patients with exon 19 del or L858R mutations solely, they were inclined to have small size adenocarcinomas which occurred in bilateral and invaded the visceral pleura. The tyrosine kinases inhibitors (TKIs)-resistant mutation, insertions in exon 20, was detected in 11 patients. Conclusions: The summarized clinicopathological features will help clinicians to implement the feasible treatment plan.
引用
下载
收藏
页码:796 / 801
页数:6
相关论文
共 50 条
  • [1] Lung cancer patients harbouring epidermal growth factor receptor mutation
    Dias, Catarina
    Araujo, David
    Magalhaes, Adriana
    Queiroga, Henrique
    Espanhol, Venceslau
    Machado, Jose
    Moura, Conceicao
    Marques, Agostinho
    Fernandes, Gabriela
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [2] Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung
    Duan, Jianchun
    Wang, Zhijie
    Bai, Hua
    An, Tongtong
    Zhuo, Minglei
    Wu, Meina
    Wang, Yuyan
    Yang, Lu
    Wang, Jie
    THORACIC CANCER, 2015, 6 (03) : 319 - 326
  • [3] Mutations in the exons of epidermal growth factor receptor gene are associated with clinicopathological features of lung cancer
    Wan, Yanhui
    Wang, Youyu
    Fang, Fuyuan
    Wu, Guodong
    Zhang, Manhua
    ASIAN JOURNAL OF SURGERY, 2020, 43 (10) : 1037 - 1038
  • [4] Epidermal growth factor receptor mutation testing in the care of lung cancer patients
    Sequist, Lecia V.
    Joshi, Victoria A.
    Jaenne, Pasi A.
    Bell, Daphne W.
    Fidias, Pahos
    Lindeman, Neal I.
    Louis, David N.
    Lee, Jeffrey C.
    Mark, Eugene J.
    Longtine, Janina
    Verlander, Peter
    Kucherlapati, Raju
    Meyerson, Matthew
    Haber, Daniel A.
    Johnson, Bruce E.
    Lynch, Thomas J.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4403S - 4408S
  • [5] Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung
    Fukui, Tomoya
    Tsuta, Koji
    Furuta, Koh
    Watanabe, Shun-ichi
    Asamura, Hisao
    Ohe, Yuichiro
    Maeshima, Akiko Miyagi
    Shibata, Tatsuhiro
    Masuda, Noriyuki
    Matsuno, Yoshihiro
    CANCER SCIENCE, 2007, 98 (11) : 1714 - 1719
  • [6] Cytologic features of lung adenocarcinoma with epidermal growth factor receptor mutation
    Nomura, M.
    Hirano, T.
    Ohira, T.
    Kakihana, M.
    Fujioka, K.
    Honda, H.
    Yoshida, K.
    Maeda, J.
    Kato, H.
    ACTA CYTOLOGICA, 2007, 51 (02) : 335 - 336
  • [7] CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma
    Liu, Ying
    Kim, Jongphil
    Qu, Fangyuan
    Liu, Shichang
    Wang, Hua
    Balagurunathan, Yoganand
    Ye, Zhaoxiang
    Gillies, Robert J.
    RADIOLOGY, 2016, 280 (01) : 271 - 280
  • [8] Association of cytokines levels with epidermal growth factor receptor mutation in lung cancer patients
    Gaur, Priyanka
    Bhattacharya, Sandeep
    Kant, Surya
    Kushwaha, R. A. S.
    Singh, Gaurav
    Pandey, Sarika
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 811 - 815
  • [9] Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma
    Lu, Chao-Wen
    Lin, Mong-Wei
    Chiang, Xu-Heng
    Hsu, Hsao-Hsun
    Hsieh, Min-Shu
    Chen, Jin-Shing
    DIAGNOSTICS, 2023, 13 (03)
  • [10] Prevalence of mutation in the epidermal growth factor receptor gene in Chinese patients with non-small cell lung cancer
    Jiang, B.
    Zhu, Z. -Z.
    Liu, F.
    Hou, L. -F.
    Gu, J.
    Chen, E.
    Tzeng, C. -M.
    Zhu, G.
    CLINICAL ONCOLOGY, 2006, 18 (08) : 635 - 635